Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1116_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments by Salman Al-Sabah
- •Contents
- •Editors and Contributors
- •Introduction
- •Learning About the Laparoscopic Sleeve Gastrectomy (lSG) The Birth and Evolution of Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •2 Costing Methods
- •3 Costing Components
- •4 Cost of Obesity and Overweight: The Evidence
- •5 Overall Cost of Obesity
- •6.1 Ischaemic Heart Disease and Stroke
- •References
- •Obesity, a Costly Epidemic
- •6.2 Diabetes Mellitus
- •6.3 Osteoarthritis
- •6.4 Cancers
- •7 Conclusion
- •References
- •The Health Effects of Obesity
- •1 Obesity Reduces Life Expectancy
- •2 Obesity and Cardiovascular Disease
- •3 Obesity and Respiratory Disease
- •4 Obesity and Cancer
- •5 Other Obesity-Related Conditions
- •6 Health Effects of Obesity in Special Populations
- •6.1 Transplant Recipients
- •6.2 Orthopedic Surgery Patients
- •6.3 Pregnancy
- •6.4 Children and Adolescents
- •7 Conclusion
- •References
- •Obesity and Body Mass Index
- •2 Obesity and BMI
- •3 Percent Excess Weight Loss (%EWL)
- •4 Percent Excess BMI loss (%EBMIL)
- •5 Percent of Total Weight Loss (%TWL)
- •References
- •Dealing with Obesity: Patient Perspective
- •1 Considering the Psychology of Obesity
- •2 Education for Success
- •3 Understanding the Necessity of Mind Shift for Success
- •The Future of Bariatric Surgery and Genetics
- •1 Heritability and Obesity
- •2 Weight Loss Interventions and Genetics
- •3 Bariatric Surgery and Genetics
- •References
- •Sleeve Gastrectomy Registries
- •1 Introduction
- •3 The Value of Registries
- •7.1 Direct-Data Entry Only
- •7.2 Electronic Upload Only
- •8 Key Step 5—Create a Suitable Minimum Dataset
- •9 Key Step 6—Layer in GDPR Compliance
- •14 Conclusion
- •References
- •Weight Loss: Diet Options
- •1 Introduction
- •2 Principles in Dietary Therapies
- •3 Diet Options for Weight Loss
- •4 The Weight-Maintenance Diet
- •5 Summary
- •References
- •Candidates for Sleeve Gastrectomy
- •Eligibility Criteria for Sleeve Gastrectomy
- •1 Introduction
- •2 Current Eligibility Criteria for Bariatric Surgery
- •3 Age
- •4 BMI
- •5 Procedure Selection
- •6 Other Considerations in Decision-Making
- •7 Summary
- •References
- •The Sleeve and Pregnancy
- •1 Pre-pregnancy Weight Management
- •2 Pre-pregnancy Supplementation
- •3 Acceptable Weight Changes in Pregnancy
- •4 Care During Pregnancy
- •5 Gestational Diabetes
- •5.1 Screening
- •5.2 Treatment
- •5.3 Mode of Delivery
- •5.4 Postpartum
- •References
- •The Sleeve and Reproductive Potential
- •1 Introduction
- •2 Obesity and Female Reproduction
- •3 Obesity and Male Reproduction
- •4 Female Reproduction Following Bariatric Surgery
- •5 Male Reproduction Following Bariatric Surgery
- •6 Timing of Conception Following Bariatric Surgery
- •8 Conclusion
- •References
- •6 RYGB to SG
- •7 SG After Endoscopic Procedures
- •8 Conclusion
- •References
- •Converting Endoscopic Bariatric Procedures to LSG: POSE, Endosleeve, and Balloon
- •1 Introduction
- •The Sleeve as a Revisional Procedure
- •1 Introduction
- •2 General Considerations
- •3 Choice of Technique Based on Evidence
- •5 Sleeve Gastrectomy to Re-sleeve
- •2 The POSE Procedure
- •2.1 How the POSE is Performed
- •2.2 Converting a POSE to an LSG
- •3 The Endosleeve
- •3.1 How the Endosleeve is Performed
- •3.2 Converting Endosleeve to LSG
- •4 The Balloon
- •4.1 LSG Following Balloon Removal
- •5 Conclusion
- •References
- •The Sleeve Gastrectomy in Adolescents
- •1 Introduction
- •2 Eligibility
- •2.1 Who is Eligible?
- •3 Which Procedure is Right for Adolescents
- •4 Pre- and Post-operative Nutritional Care
- •5 Psychological Concern
- •6 The Outcomes of SG
- •References
- •2 Epidemiology
- •3 Risk Factors
- •4 Pathophysiology
- •5 Clinical Presentation
- •6 Diagnosis
- •7 Non-invasive Tests
- •7.1 Laboratory Investigations
- •7.2 Imaging
- •8 Scoring Systems
- •8.1 Invasive Measure
- •8.1.1 Liver Biopsy
- •9 Clinical Scores
- •10 Sleeve Gastrectomy in NAFLD and NASH
- •13 Sleeve Gastrectomy Pre-transplant
- •15 Sleeve Gastrectomy After Liver Transplantation
- •References
- •Sleeve Gastrectomy in Immunocompromised Patients
- •1 Introduction
- •2 Safety and Postoperative Morbidity
- •2.2 Perioperative Timing of Immunosuppressive Therapy
- •3 Outcomes of SG in Immunocomromised Patients
- •3.2 Changes to Rheumatoid and Autoimmune Conditions
- •4 Summary
- •References
- •Sleeve Gastrectomy and Cancer
- •1 Obesity and Cancer
- •2 Pathogenesis of Cancer in the Obese
- •3 Current Literature
- •4 Bariatric Surgery and Cancer Risk
- •5 Colorectal Cancer (CRC)
- •6 CRC in RYGB Versus SG and AGB
- •7 Breast and Endometrial Cancers
- •8 SG and Gastro-esophageal Cancer
- •9 Conclusion
- •References
- •Multidisciplinary Care Before and After Sleeve Gastrectomy
- •1 Introduction
- •2 Bariatric/Obesity Specialist
- •3 Bariatric Dietitian
- •4 Bariatric Clinical Psychologist
- •5 Bariatric Coordinator
- •6 Conclusion
- •References
- •Psychiatric Evaluation: Pre and Post Sleeve
- •1 Introduction
- •3 Depression
- •4 Eating Disorders
- •5 Anxiety
- •6 Substance Use Disorders
- •7 Self-harm and Suicidal Ideation
- •8 Psychotropic Medications
- •10 Mental Health Preoperative Assessment
- •11 Outline of Domains of the Evaluation
- •12 Psychiatric Contraindications for Bariatric Surgery
- •13 Conducting the Assessment
- •13.1 History of Weight Loss and Previous Attempts
- •13.2 Medical History
- •13.3 Pathological Eating Behavior
- •13.4 Psychiatric History and Screening of Substance Use
- •13.5 Support System
- •13.6 Psychiatric Medication
- •14 Psychiatric Assessment Conclusion
- •15 Special Populations
- •15.1 The Adolescent Patient
- •15.2 Limited Cognitive Function
- •16 The Impact of Bariatric Surgery on Mental Health
- •16.1 Quality of Life
- •16.2 Mental health status
- •16.3 Suicide
- •16.4 Addiction
- •16.5 Eating Disorders
- •16.6 Psychotropic Medication
- •16.7 Postoperative Pharmacological Considerations
- •17 Conclusion
- •References
- •Insurance, Self-Pay and Medical Tourism
- •How Much Does the Sleeve Cost
- •1.1 Economic Methodologies
- •1.2 Fixed Costs: Medical Devices
- •1.3 Fixed Costs: Personnel
- •1.4 Variable Costs: Reusable Instruments
- •1.5 Variable Costs: Disposables
- •2 Bariatric Surgery Costs
- •2.1 Methods for Identifying Cost Components
- •2.2 Methods for Valuing Cost Components
- •3 The Cost of the Sleeve Around the World
- •References
- •Analysis of LSG Competitors
- •1 Competition in the Industry
- •2 Potential of New Entrants into the Industry
- •3 Threat of Substitute Products
- •3.1 Anti-obesity Medications
- •3.2 Herbal and Alternative Medicine
- •3.3 Diet Program
- •3.4 Exercise
- •3.5 Acupuncture and Acupressure for Weight Loss
- •4 Power of Customers
- •5 Power of Suppliers
- •5.1 Strengths
- •5.2 Weaknesses
- •5.3 Weaknesses of Duodenal Switch Surgery
- •5.4 Opportunities
- •5.5 Threats
- •References
- •Medical Tourism: Global Bariatric Healthcare
- •1 Introduction
- •2 The Impetus Behind Global Healthcare
- •4 Conclusion
- •References
- •Sleeve Gastrectomy: Medicolegal Aspects
- •References
- •Laparoscopic Sleeve Gastrectomy 101
- •References
- •Robotic Sleeve Gastrectomy
- •1 Introduction
- •2 Robotic-Assisted Sleeve Gastrectomy
- •3 Cost of Robotic-Assisted Sleeve Gastrectomy
- •5 Operative Technique
- •6 Clinical Outcomes
- •7 Future Directions
- •8 Conclusion
- •References
- •Laparoscopic Sleeve Gastrectomy in Situs Inversus Totalis
- •1 Introduction
- •2 How to Perform the Procedure
- •3 Discussion
- •4 Conclusion
- •References
- •Banded Sleeves
- •1 Introduction
- •2 Procedure
- •3 Pre- Intra- and Post-Operative Management
- •4 Results
- •5 Band Complications
- •7 Conclusions
- •References
- •Buttressing the Sleeve
- •1 Introduction
- •2 Technical Aspects
- •3 Buttressing for Bleeding
- •4 Buttressing for Leaks
- •5 Results from the MBSAQIP
- •6 Previous Evidence
- •7 Conclusion
- •References
- •Sleeve and Ventral Hernias
- •1 Introduction
- •2 Prevalence, Incidence and Cost of Ventral Hernia
- •4 Primary Abdominal Wall Hernia
- •5 Incisional Hernia
- •5.1 Medial or Midline Zone
- •5.2 Lateral Hernias (Flank Hernias)
- •6 Size of the Hernia
- •7 Indication and Risks of Ventral Hernia Repair
- •8.1 Position of Trocar and Creation of Pneumoperitoneum
- •9 Principles of Adhesiolysis
- •10 Measurement of Hernia Defect
- •12 Technique of Open Ventral Hernia Repair [10, 25, 26]
- •13 Concurrent LSG with LVHR
- •14 LSG with Sequential LVHR
- •15 Conclusion
- •References
- •1 Introduction
- •5 Operative Concerns and Patient Selection
- •6 Preoperative Evaluation
- •7 Esophageal High-resolution Manometry
- •8 Surgical Technique
- •9 Discussion
- •References
- •Omentopexy in Laparoscopic Sleeve Gastrectomy
- •1 Background
- •3 Omentopexy in Sleeve Gastrectomy
- •3.2 Operative Technique
- •5 Effect on Gastric Emptying
- •6 Conclusion
- •References
- •Sleeve Gastrectomy and Gallstones Disease
- •1 Introduction
- •2 Obesity and the Risk of Gallstone
- •3 Rapid Weight Loss and the Risk of Gallstone
- •5 Incidence of Cholecystectomy in Sleeve Gastrectomy
- •6 Biliary Complications Post LSG
- •7 Cholecystectomy: When to Operate?
- •8 Prophylactic (Routine) Cholecystectomy
- •9 Elective (Selective) Cholecystectomy:
- •11 Ursodeoxycholic Acid (UDCA) Prophylaxis
- •12.1 Dose, Frequency
- •13 Disadvantages of UDCA
- •14 Summary
- •15 Conclusion
- •References
- •LSG Under Block Anesthesia (PVB)
- •1 Introduction
- •2 Review on General Anesthesia
- •2.1 General Overview
- •2.2 General Anesthesia in the Obese/bariatric Population
- •3 Review on Paravertebral Block (PVB)
- •4 Anatomy
- •4.1 Indication
- •4.2 Techniques
- •4.2.1 Blind Technique
- •4.2.2 Neurostimulation Technique
- •4.2.3 Ultrasound Guided Technique
- •4.3 Mechanism and Spread of Anesthetic
- •4.4 Anesthetic Drugs
- •4.5 Complications
- •4.6.1 Abdominal Surgeries
- •4.6.2 First Paravertebral Block in Sleeve Gastrectomy
- •References
- •Elderly High Risk Patients Undergoing Laparoscopic Sleeve Gastrectomy
- •1 Scope of the Problem
- •1.1 Increasing of the Elderly Population
- •1.3 Risks of Surgery in the Elderly
- •1.3.1 Bariatric Surgery in Elderly
- •2 Sleeve Gastrectomy: Procedure of Choice
- •2.1 Intraoperative Difference in Elderly
- •3 Postoperative Care in the Elderly
- •4 Postoperative Mortality and Morbidity
- •5 Postoperative Outcomes
- •5.1 Excess Body Weight Loss
- •5.2 Comorbidities Improvement
- •5.3 Quality of Life Improvement
- •6 LSG in Septuagenarians and Elderly Super Obese
- •7 LSG Compared to Gastric Bypass in Elderly
- •8 Conclusions
- •References
- •Postoperative Diet Progression for Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •2 Diet Progression: Stages
- •3 Conclusion
- •References
- •How Laparoscopic Sleeve Gastrectomy May Cause Weight Loss
- •1 Ghrelin Effect
- •1.1 Other Gastrointestinal Hormone Secretion
- •1.2 Other Molecular Changes
- •1.3 Bile Acid Metabolism
- •1.4 Microbiome
- •1.5 Central Nervous System Changes
- •1.6 Conclusion
- •References
- •Expected Weight Loss After the Sleeve
- •1 Introduction
- •2 Preoperative Weight Loss
- •3 Short-Term and Mid-Term Outcomes
- •4 Long-Term Outcomes
- •6 Summary
- •References
- •1 Introduction
- •2 Set Point Theory
- •3 Weight Regulation and Weight Loss Maintenance
- •6 Neurohormonal Regulation of the Body Set Point
- •8 Conclusions
- •References
- •Quality of Life and Bariatric Surgery
- •1 Medical Outcomes Survey Short Form 36S (SF-36)
- •3 The Bariatric Quality of Life Index (BQL)
- •References
- •LSG: Risks and Considerations
- •Risks Associated with Sleeve Gastrectomy
- •References
- •Outcomes and Complications After Sleeve Gastrectomy
- •1 Introduction
- •2 Impact on Obesity
- •3 Impact on Diabetes
- •4 Impact on Hypertension
- •5 Impact on Dyslipidaemia
- •6 Complications
- •7 Non-Surgical Complications of Sleeve Gastrectomy
- •9 Early Complications of Sleeve Gastrectomy
- •10 Alteration to Bile Flow After Sleeve Gastrectomy
- •11 Anatomical Changes After Sleeve Gastrectomy
- •12 Vagus Nerve Modulation After Sleeve Gastrectomy
- •13 Cardiovascular Effects of Sleeve Gastrectomy
- •14 Effects on Microbiota After Sleeve Gastrectomy
- •15 Impact on Metabolism After Bariatric Surgery
- •16 Conclusion
- •References
- •How to Manage Sleeve Complications: Hemorrhage
- •1 Background
- •2 Bleeding Cascade, Patient and Surgeon Factor
- •3 Surgical Stapler Technology
- •4 Management and Prevention
- •4.1 Buttressing, Oversewing
- •5 Hemostats
- •6 Summary
- •References
- •Endoscopic Management of Leak and Abscess Following Laparoscopic Sleeve Gastrectomy
- •1 Introduction
- •3 Closure of the Leak Site
- •3.1 Self-Expanding Metal Stents
- •3.2 Types of SEMS
- •3.3 SEMS Insertion Procedure
- •3.4 Outcome of SEMS Placement
- •3.5 Over-The Scope Clip System
- •4 Internal Drainage
- •4.1 Endoscopic Internal Drainage
- •4.2 EID Procedure
- •4.3 Outcome of EID Procedure
- •4.4 Endoscopic Vacuum Therapy
- •5 Septotomy and Pneumatic Balloon Dilatation
- •6 Conclusion
- •References
- •How to Manage Sleeve Complications: Surgical Leak and Abscess
- •1 Introduction
- •2 Principles of Management
- •3 Endoscopy
- •4 Surgery
- •4.1 Control of Early Complications and Nutritional Status
- •4.2 The Leak Site
- •4.3 Roux en Y Fistulo-Jejunostomy
- •4.4 Literature Review of the Remaining Surgical Options
- •4.5 Discussion of the Surgical Approach
- •5 Conclusion
- •References
- •How to Manage Sleeve Complications Through Endoscopy: Strictures
- •1 Introduction
- •4 Signs and Symptoms
- •5 Diagnosis and Management
- •6 Bougie Dilation
- •8 Self-Expanding Metal Stent (SEMS) Placement
- •10 Strategies for Endoscopic Success
- •11 Conclusions
- •References
- •Sleeve Gastrectomy Stenosis: Surgical Treatment
- •1 Introduction
- •2 Diagnosis
- •3 Incidence
- •4 Prevention
- •5 Treatment
- •6 Conclusion
- •References
- •1 Introduction
- •2 Mechanisms of GERD Post-Sleeve Gastrectomy
- •3 Incidence of GERD After Sleeve Gastrectomy
- •4 Screening Recommendations
- •5 Role of Pharmacotherapy, Diagnosis, and Testing
- •7 Radiofrequency Ablation
- •8 Transoral Incisionless Fundoplication (TIF)
- •9 Conclusion
- •References
- •1 Background
- •2 Pathophysiology

Fig. 3 Types of products
used for buttressing
S. Taha264
Carbonate buttress material (Seamguard Bioabsorbable, W. L. Gore & Associates)
adds a total thickness of 0.5 mm while the absorbable Glycolide Diaxonone
Trimethylene Carbonate product that comes integrated\pre-loaded onto the
Stapler Cartridge (Covidien) adds a total thickness of 0.14 mm. Consideration of
the additional thickness of the buttressing material used is of paramount relevance
to the safety of the procedure since stapling through a “tissue plus buttress” complex that is too thick for the chosen stapler height will result in deformed staple
formation and\or tissue injury, while deploying a stapler on a “tissue plus buttress” complex that is too thin for its height can result in instantaneous staple line
leakage [15–17].
3 Buttressing for Bleeding
The other major complication of LSG is post-operative bleeding which can be
either intra- or extraluminal. Intraluminal bleeding from the staple line is rather
uncommon and usually presents with signs and symptoms of upper gastrointestinal bleeding including hematemesis and\or melena stools depending on the
severity and duration of the bleeding [22]. Diagnosis and management of intraluminal bleeding follows the standard algorithm for upper gastrointestinal bleeding,
including blood transfusion, if needed.

Buttressing the Sleeve
Fig. 4 Levels of evidence
265
Extraluminal bleeding can present as an “acute” episode with full blown clinical picture of hypovolemia and\or significant serial drop of hemoglobin or assume
a subclinical course that presents mainly as relative tachycardia, mild pallor and
dizziness, especially on standing up quickly.
Acute bleeding is reported with a frequency that ranges from 1.7% [23] to
2.8% [24] and usually requires return to the operating room (OR) with some sort
of operative intervention, mostly laparoscopic. Subclinical bleeding, on the other
hand, occurs in up to 7.7% of cases [24] and is managed quite effectively in a conservative manner.
Although some studies concluded that buttressing didn’t produce a favorable
effect on bleeding following LSG [25, 26], most investigators, by far, agree that
buttressing of the staple line in LSG reduces bleeding compared to patients that
receive no buttressing [8, 12, 27–29]. Some studies showed more favorable results
for some types of buttressing materials against the others when it comes to bleeding [30, 31] but there were too many variables involved in those studies to support this finding. It is noteworthy that such a superiority was not reproduced in
several other similar studies. When compared to over sewing, the other technique
that reduces staple line bleeding in LSG, buttressing was found to produce similar,
or better, hemostatic outcomes without the inherent complications of over sewing,
namely longer operative time [12, 27] and stenosis of the sleeve tube lumen [32].
Over sewing was also found to be associated with a significantly higher rate of
post-operative nausea and vomiting to the point that it increased the duration of

S. Taha266
the symptoms during the first hours after surgery and prevented early oral intake
compared to buttressing [33].
Furthermore, buttressing of the staple line was reported not only to reduce the
rate of staple line bleeding itself directly, but also significantly reduced the number
of surgical clips required to achieve hemostasis [34, 35] and the overall rate of
post-LSG complications [6] including bleeding-related re-operation [29].
4 Buttressing for Leaks
Unlike bleeding, the role of buttressing in reducing the incidence of leak from the
staple line has been, for a long time, controversial. Several investigators reported
that buttressing the staple line didn’t improve the outcome when it came to leaks
[26, 36, 37]. There has been, however, growing evidence lately that buttressing
actually reduces the incidence of staple line leak in LSG, with an increasing number of researchers reporting a significant improvement in leak rates with buttressing of the staple line when compared to non-buttressing [6, 38–42].
5 Results from the MBSAQIP
One extremely controversial report that caused a lot of noise, when published in
2016, was the first report from the Metabolic and Bariatric Surgery Accreditation
and Quality Improvement Program (MBSAQIP) [43]. The researchers went
through the MBSAQIP data registry for 189,477 LSG cases that were performed
from 2012 to 2014, assessed the effect of various surgical techniques used in them
on the 30-day outcomes, and evaluated their impact on weight loss and comorbidities one year following the procedure. From that report, they were able to conclude that staple line reinforcement (SLR) was associated with an increased leak
rate. So many variables, however, were involved in the design of this study, which
questioned the credibility of this conclusion. More than 1600 surgeons, each with
their own different techniques and preferences, performed the procedures at 720
centers, each with their own different protocols and set up. Furthermore, a wide
range of different consumables were used by different surgeons\centers, making
it very difficult to identify the factor(s) that could have contributed to the relatively higher rate of leak reported in this study following LSG with SLR (0.96%)
compared to no SLR (0.65%). Strangely enough, the researchers reported that staple line leak was directly, and significantly, related to a bougie size; that is less
than 38 F (0.96%) compared to more than 38 F (0.80%), but they still managed
to contribute the higher incidence of leak to buttressing the staple line. It is worth
mentioning that a later, well-structured study of the MBSAQIP database proved
that this, rather surprising conclusion was actually unfounded. The researchers
went through the MBSAQIP Participant Use File data for 198,339 primary LSG
cases that were performed during the years 2015–2016, assessed all the variables
that were related to leak rate and used multiple bivariate analyses to evaluate the

Buttressing the Sleeve
30-day outcomes. They concluded that buttressing was associated with reduced
rates of bleeding and reoperations but not with a higher incidence of leak [29].
267
6 Previous Evidence
Cesana et al., in 2018, published the results of their analysis of the predictors of
leak in 1738 consecutive LSG procedures and concluded that buttressing of the
staple line significantly reduced the risk of bleeding (P < 0.05) [44]. Gagner and
Kemmeter studied the leak rate following LSG with 5 different staple line reinforcement methods though a systemic review of all the papers that were published
between 2012 and 2016 and concluded that buttressing was not only associated
with a lower rate of leak compared with no reinforcement, but also that its effectiveness was significantly better when compared to that of over-sewing or sealants
[45].
7 Conclusion
8 Types of buttressing materials that are coomercially
available (Fig. 3)
The main buttressing materials that are currently used in bariatric surgery are
(alphabetically):
– Neoveil, an absorbable polyglycolic acid felt; Gunze Medical. This is the mate-
rial that is used in Medtronic’s latest released “Pre-loaded” Reinforced car-
tridges with Tristapler technology.
– Peristrips Dry; permanent bovine pericardial strips; Baxter Healthcare
(Formerly Synovis)
– Peristrips Dry with Veritas; remodelable collagen matrix strips; Baxter
Healthcare (Formerly Synovis)
– Seamguard; a synthetic bioabsorbable glycolide trimethylene carbonate copoly-
mer; WL Gore & Associates.
– Surgisis Biodesign; Remodelable small intestinal submucosa strips that are
coated with fructose self-adhesive; Cook Medical.
However, it is important to note that very few direct comparisons of one material
to another have been reported. In one, nonrandomized, study, bovine pericardial
strips were compared with polyglycolide/trimethylene carbonate buttress material. This study found a significantly greater incidence of leaks in the latter group;
but importantly, the authors used the same stapler (3.5 mm staple height) in both
groups [46] and, because the polyglycolide/trimethylene carbonate product is significantly thinner than the bovine pericardial product, the increased leak rate may

S. Taha268
be attributable to their use of the same stapler with buttress materials of significantly different thicknesses.*
Other large series that compared essentially the same products reported contradicting outcomes with varying levels of evidence [31, 45]; Fig. 4.
References
1. Nguyen NT, Longoria M, Chalifoux S, Wilson SE. Bioabsorbable staple line reinforcement
for laparoscopic gastrointestinal surgery. Surg Technol Int. 2005;14:107–11.
2. Downey DM, Ali S, Goldblatt MI, Saxe JM, Dolan JP. Gastrointestinal staple line reinforce-
ment. Surg Technol Int. 2007;16:55–60.
3. Shikora SA, Kim JJ, Tarnoff ME. Reinforcing gastric staple-lines with bovine pericar-
dial strips may decrease the likelihood of gastric leak after laparoscopic Roux-en-Y gastric
bypass. Obes Surg. 2003;13(1):37–44.
4. Miller KA, Pump A. Use of bioabsorbable staple reinforcement material in gastric bypass: a
prospective randomized clinical trial. Surg Obes Relat Dis. 2007;3(4):417–21.
5. Assalia A, Ueda K, Matteotti R, Cuenca-Abente F, Rogula T, Gagner M. Staple-line rein-
forcement with bovine pericardium in laparoscopic sleeve gastrectomy: experimental comparative study in pigs. Obes Surg. 2007;17(2):222–8.
6. Daskalakis M, Berdan Y, Theodoridou S, Weigand G, Weiner RA. Impact of surgeon experi-
ence and buttress material on postoperative complications after laparoscopic sleeve gastrectomy. Surg Endosc. 2011;25(1):88–97.
7. Cunningham-Hill M, Mazzei M, Zhao H, Lu X, Edwards MA. The Impact of Staple Line
Reinforcement Utilization on Bleeding and Leak Rates Following Sleeve Gastrectomy
for Severe Obesity: a Propensity and Case-Control Matched Analysis. Obes Surg.
2019;29(8):2449–63.
8. Zafar SN, Felton J, Miller K, Wise ES, Kligman M. Staple line treatment and bleeding after
laparoscopic sleeve gastrectomy. JSLS. 2018;22(4).
9. Mocanu V, Dang J, Ladak F, Switzer N, Birch DW, Karmali S. Predictors and outcomes of
bleed after sleeve gastrectomy: an analysis of the MBSAQIP data registry. Surg Obes Relat
Dis. 2019;15(10):1675–81.
10. Parikh M, Issa R, McCrillis A, Saunders JK, Ude-Welcome A, Gagner M. Surgical strate-
gies that may decrease leak after laparoscopic sleeve gastrectomy: a systematic review and
meta-analysis of 9991 cases. Ann Surg. 2013;257(2):231–7.
11. Abou Rached A, Basile M, El Masri H. Gastric leaks post sleeve gastrectomy: review of its
prevention and management. World J Gastroenterol. 2014;20(38):13904–10.
12. Wang Z, Dai X, Xie H, Feng J, Li Z, Lu Q. The efficacy of staple line reinforcement during
laparoscopic sleeve gastrectomy: A meta-analysis of randomized controlled trials. Int J Surg.
2016;25:145–52.
13. Bashah M, Khidir N, El-Matbouly M. Management of leak after sleeve gastrectomy:
outcomes of 73 cases, treatment algorithm and predictors of resolution. Obes Surg.
2020;30(2):515–20.
14. Leonard-Murali S, Nasser H, Ivanics T, Shakaroun D, Genaw J. Perioperative Outcomes of
Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an
Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement
Program (MBSAQIP) Database. Obes Surg. 2020;30(1):111–8.
15. Downey DM, Harre JG, Dolan JP. Increased burst pressure in gastrointestinal staple-lines
using reinforcement with a bioprosthetic material. Obes Surg. 2005;15:1379–83.
16. Arnold W, Shikora SA. A comparison of burst pressure between buttressed versus
non-buttressed staple-lines in an animal model. Obes Surg. 2005;15:164–71.

Buttressing the Sleeve
17. Baker RS, Foote J, Kemmeter P, Brady R, Vroegop T, Serveld M. The science of stapling and
leaks. Obes Surg. 2004;14:1290–8.
18. Shikora SA. The use of staple-line reinforcement during laparoscopic gastric bypass. Obes
Surg. 2004;14:1313–20.
19. Assalia A, Ueda K, Matteotti R, et al. Staple-line reinforcement with bovine pericardium
in laparoscopic sleeve gastrectomy: experimental comparative study in pigs. Obes Surg.
2007;17:222–8.
20. Consten EC, Gagner M, Pomp A, Inabnet WB. Decreased bleeding after laparoscopic sleeve
gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed
absorbable polymer membrane. Obes Surg. 2004;14:1360–6.
21. Basu NN, Leschinskey D, Heath DI. The use of Seamguard to buttress the suture repair of a
staple line leak following laparoscopic gastric bypass for obesity. Obes Surg. 2008;18:896–7.
22. Kourosh S, Daniel WB, Arya S, Shahzeer K. Complications associated with laparoscopic
sleeve gastrectomy for morbid obesity: a surgeon’s guide. Can J Surg. 2013;56(5):347–52.
23. De Angelis F, Abdelgawad M, Rizzello M, Mattia C, Silecchia G. Perioperative hemorrhagic
complications after laparoscopic sleeve gastrectomy: four-year experience of a bariatric
center of excellence. Surg Endosc. 2017;31(9):3547–51.
24. Spivak H, Azran C, Spectre G, Lidermann G, Blumenfeld O. Sleeve Gastrectomy
Postoperative Hemorrhage is Linked to Type-2 Diabetes and Not to Surgical Technique.
Obes Surg. 2017;27(11):2927–32.
25. Albanopoulos K, Alevizos L, Flessas J, et al. Reinforcing the staple line during laparoscopic
sleeve gastrectomy: prospective randomized clinical study comparing two different techniques Preliminary Results. Obes Surg. 2012;22:42–6.
26. Simon TE, Scott JA, Brockmeyer JR, Rice RC, Frizzi JD, Husain FA, Choi YU. Comparison
of staple-line leakage and hemorrhage in patients undergoing laparoscopic sleeve gastrectomy with or without Seamguard. Am Surg. 2011;77(12):1665–8.
27. Shah SS, Todkar JS, Shah PS. Buttressing the staple line: a randomized comparison between
staple-line reinforcement versus no reinforcement during sleeve gastrectomy. Obes Surg.
2014;24(12):2014–20.
28. Guerrier JB, Mehaffey JH, Schirmer BD, Hallowell PT. Reinforcement of the Staple
Line during Gastric Sleeve: A Comparison of Buttressing or Oversewing, versus No
Reinforcement- A Single-Institution Study. Am Surg. 2018;84(5):690–4.
29. Demeusy A, Sill A, Averbach A. Current role of staple line reinforcement in 30-day out-
comes of primary laparoscopic sleeve gastrectomy: an analysis of MBSAQIP data, 2015–
2016 PUF. Surg Obes Relat Dis. 2018;14(10):1454–61.
30. David Spector, Zvi Perry, Tracy Konobeck, Daniel L Mooradian, Scott Shikora. Comparison
of hemostatic properties between collagen and synthetic buttress materials used in staple
line reinforcement in a swine splenic hemorrhage model. Technological Leadership Institute
(2011).
31. Shikora SA, Mahoney CB. Clinical Benefit of Gastric Staple Line Reinforcement (SLR) in
Gastrointestinal Surgery: a Meta-analysis. Obes Surg. 2015;25:1133–41.
32. Guerrier JB1, Mehaffey JH, Schirmer BD, Hallowell PT. Reinforcement of the staple line
during gastric sleeve: a comparison of buttressing or oversewing, versus no reinforcement—a
single-institution study. Am Surg. 2018;84(5):690–4.
33. Ruiz-Tovar J, Zubiaga L, Muñoz JL, Llavero C. Incidence of postoperative nausea and vom-
iting after laparoscopic sleeve gastrectomy with staple line reinforcement with oversewing and staple line inversion vs buttressing material: A randomized clinical trial. Int J Surg.
2018;59:75–9.
34. Angrisani L, Lorenzo M, Borrelli V, et al. The use of bovine pericardial strips on linear sta-
pler to reduce extraluminal bleeding during laparoscopic gastric bypass: prospective randomized clinical trial. Obes Surg. 2004;14:1198–202.
269

S. Taha270
35. Nguyen NT, Longoria M, Welbourne S, et al. Glycolide copolymer staple-line reinforcement
reduces staple site bleeding during laparoscopic gastric bypass: a prospective randomized
trial. Arch Surg. 2005;140:773–8.
36. Chen B, Kiriakopoulos A, Tsakayannis D, Wachtel MS, Linos D, Frezza EE. Reinforcement
does not necessarily reduce the rate of staple line leaks after sleeve gastrectomy. A review of
the literature and clinical experiences. Obes Surg. 2009;19(2):166–72.
37. Timucin Aydin M, Aras O, Karip B, Memisoglu K. Staple line reinforcement methods in lap-
aroscopic sleeve gastrectomy: comparison of burst pressures and leaks. JSLS. 2015;19(3).
38. Yo LS, Consten EC, Quarles van Ufford HM, Gooszen HG, Gagner M. Buttressing of the
staple line in gastrointestinal anastomoses: overview of new technology designed to reduce
perioperative complications Dig Surg. 2006;23(5–6):283–91.
39. Glaysher M, Khan OA, Mabvuure NT, Wan A, Reddy M, Vasilikostas G. Staple line rein-
forcement during laparoscopic sleeve gastrectomy: does it affect clinical outcomes? Int J
Surg. 2013;11(4):286–9.
40. Al Hajj GN, Haddad J. Preventing staple-line leak in sleeve gastrectomy: reinforcement with
bovine pericardium vs. oversewing. Obes Surg. 2013;23(11):1915–21.
41. Durmush EK1, Ermerak G, Durmush D. Short-term outcomes of sleeve gastrectomy for mor-
bid obesity: does staple line reinforcement matter? Obes Surg. 2014;24(7):1109–16.
42. Iossa A, Abdelgawad M, Watkins BM, Silecchia G. Leaks after laparoscopic sleeve
gastrectomy: overview of pathogenesis and risk factors. Langenbecks Arch Surg.
2016;401(6):757–66.
43. Berger ER, Clements RH, Morton JM, Huffman KM, Wolfe BM, Nguyen NT, Ko CY, Hutter
MM. The Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve
Gastrectomies: The First Report from the Metabolic and Bariatric Surgery Accreditation and
Quality Improvement Program (MBSAQIP). Ann Surg. 2016;264(3):464–73.
44. Cesana G, Cioffi S, Giorgi R, Villa R, Uccelli M, Ciccarese F, Castello G, Scotto B, Olmi S.
Proximal Leakage After Laparoscopic Sleeve Gastrectomy: an Analysis of Preoperative and
Operative Predictors on 1738 Consecutive Procedures. Obes Surg. 2018;28(3):627–35.
45. Gagner M, Kemmeter B. Comparison of laparoscopic sleeve gastrectomy leak rates in five
staple-line reinforcement options: a systematic review. Surg Endosc. 2020;34(1):396–407.
46. Shikora SA, Kim JJ, Tarnoff ME. Comparison of permanent and nonpermanent staple line
buttressing materials for linear gastric staple lines during laparoscopic Roux-en-Y gastric
bypass. Surg Obes Relat Dis. 2008;4(6):729–34.

Sleeve and Ventral Hernias
Meshari Almuhanna and Wei-Jei Lee
1 Introduction
Obesity is a major risk factor for many metabolic diseases, including diabetes,
cardiovascular disease, sleep apnea, musculoskeletal disorders and some cancers.
The number of obese people is increasing worldwide; according to WHO since the
number of obese people nearly tripled [1]. Surgical treatment of Obesity (Bariatric
Surgery) is concomitantly increasing worldwide [2]. Bariatric surgeries that are
most commonly performed are laparoscopic sleeve gastrectomy (LSG) followed
by Roux-en-Y gastric bypass (RYGB) [3].
There is a strong association between developing ventral hernia and obesity
[4, 5]. Furthermore, obesity in itself also increases the risk and failure of ventral
hernia repair. Being obese and having ventral hernia makes performing bariatric
surgery a challenge. Can it be done in concomitant with LSG is the question. In
this chapter we will focus on what is the best approach for an obese patient with
ventral hernia who has chosen to undergo an LSG.
M. Almuhanna (*)
Bariatric & Metabolic Surgery Unit, Department of General Surgery, Jaber Al-Ahmad
Al-Sabah Hospital, Kuwait, Kuwait
e-mail: almuhanna@moh.gov.kw
M. Almuhanna · W.-J. Lee
Asia-Pacific Endoscopic Bariatric and Metabolic Surgical Center, Min-Sheng General
Hospital, Taoyuan, Taiwan
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer
Nature Switzerland AG 2021
S. Al-Sabah et al. (eds.), Laparoscopic Sleeve Gastrectomy,
https://doi.org/10.1007/978-3-030-57373-7_29
271

M. Almuhanna and W.-J. Lee272
2 Prevalence, Incidence and Cost of Ventral Hernia
Ventral hernia (VH) is defined as an anterior abdominal wall fascia defect with
protrusion of internal content [6]. Incidence of VH is increased between the 3rd
and 6th decade of life and highest between 41–50 years of age. Incisional hernia and umbilical hernia are both the most common type of VH. Umbilical hernia is common in male (M:F – 1.5:1) where incisional hernia is more common in
females (F:M 2.3:1) [4]. It has also been proven that there is a significant association between smoking, alcohol, obesity and VH.
Obesity is a major risk factor for developing VH but the incidence of VH varies by location due to different etiological factors [4]. Incisional hernia is a common long-term complication of abdominal surgery with an incidence of 3–13% of
laparotomy incisions [5]. Priti Prasad et al. reported a series of 200 cases of VH
of hospital admissions and found the most common type to be incisional hernia
(41%) followed by umbilical (32%), paraumbilical (17%) and epigastric (10%) [4].
In another report, Jaykar, R.D. et al. also found that the most common VH is incisional hernia with an incidence of 41% of hospital admission [5]. Infra-umbilical
incisional hernia (42%) was the most common site of incisional hernia followed by umbilical incisional hernia (32%). He found the mean age of VH to be
41 years of age, with male to female ratio 1:1.9. Other than obesity, constipation
was the major predisposing risk factor of developing VH. They also noticed that
small defects (<2 cm) presented early with complication [5]. Poulose BK et al.
found the number of inpatient VH repairs (VHR) in the United States increased
from 126,548 in 2001 to 154,278 in 2006. Furthermore, an estimate of 348,000
outpatient VHRs were done in 2006 [7]. This is burden on healthcare systems,
although the majority of cases were performed as an emergency [8]. The cost of
VHR for 2006 in US was $3.2 billion. Incidence of VHR is rising, and by reducing
the recurrence rate alone, it would save $32 million dollar in the US alone for each
1% reduction in operation [7]. Raquel Maia et al. in their review article, confirmed
that obesity alone is a risk factor for both primary and incisional hernia. Further,
obese individuals are at a high risk of having co-morbidities which significantly
increase the risk of perioperative complications and recurrence rates of VHR [9].
In addition, there is a positive correlation between the size of the hernia defect
and obesity: the higher the body mass index (BMI), the bigger the defect size [9].
Similarly, the recurrence rate is also higher in obese people with a higher BMI [9,
10]. Furthermore, obesity itself is an independent risk factor of longer hospital stay,
surgical site infection, recurrence and re-admission after VHR [11, 12].
3 Diagnosis and Classification of Ventral Hernia
in Obese Patients
The clinical presentation of ventral hernias varies depending on the size and
location of the hernia and weather it is symptomatic (pain, bulge, discomfort) or
asymptomatic. A complete history and physical examination are very important

Sleeve and Ventral Hernias
273
for obese patients with ventral hernias. In non-obese patients, ventral hernia can be
easily diagnosed but in obese patients it usually requires additional imaging studies to diagnose. Murphy KP et al. found in his study that physical examination of
obese patients with suspected ventral hernia are difficult to diagnose and the best
modality for diagnoses is to do abdominopelvic computed tomography (CT) [13].
It helps identifying the hernia site, size and the content of the hernia sac in both
acute and elective circumstances (Figs. 1 and 2).
In classification of VH, they are classified into primary abdominal wall hernia and incisional hernia bases on the recommendation of the European Hernia
Society (EHS) classification [14, 15].
4 Primary Abdominal Wall Hernia
The classification of primary abdominal wall hernia is based on localization and
size of the hernia (Table 1).
Fig. 1 CT scan of obese patient with ventral hernia showing omental content without sign of
complication
Соседние файлы в папке Библиотека им академика М.И. Перельмана
